Publications by authors named "Shaowei Pang"
Am J Transl Res
September 2024
Article Synopsis
- The study aimed to assess the effectiveness of SGLT2 inhibitors, particularly dapagliflozin, in halting the progression of diabetic kidney disease and improving renal health management for patients with diabetes.
- A retrospective analysis was performed on 178 diabetic kidney disease patients, comparing those who received early versus late treatment with dapagliflozin, focusing on various health markers such as blood glucose levels and renal function.
- Results indicated that early treatment significantly improved blood glucose and renal function compared to late treatment, with both groups showing similar rates of adverse reactions (6.82% for early vs. 10.00% for late), suggesting the advantage of initiating SGLT2 inhibitors earlier in diabetic patients.
